Table 1.
Institutional representation of stakeholders in focus group discussions.
| Focus group I health aspects | Focus group II pharmaceutical aspects | Focus group III legislative aspects | |||
|---|---|---|---|---|---|
| Informant | Institution | Informant | Institution | Informant | Institution |
| FG I-I1 | University hospital | FG II-I1 | State administration | FG III-I1 | State administration |
| FG I-I2 | Medical Institute | FG II-I2 | Medical Institute | FG III-I2 | Health insurance fond |
| FG I-I3 | University hospital | FG II-I3 | Pharmacist Society | FG III-I3 | Health insurance fond |
| FG I-I4 | Medical Society | FG II-I4 | Pharmacy operator | FG III-I4 | State administration |
| FG I-I5 | Clinical center | FG II-I5 | Pharmacist Society | FG III-I5 | University hospital |
| FG I-I6 | Medical Society | FG II-I6 | Pharmacist Society | FG III-I6 | University hospital |
| FG I-I7 | Medical Society | FG II-I7 | Patient organization | FG III-I7 | Patient organization |
| FG I-I8 | Patient organization | FG II-I8 | Patient organization | FG III-I8 | Patient organization |
| FG I-I9 | Patient organization | FG II-I9 | Pharmacist Society | FG III-I9 | Medical Society |
| FG I-I10 | Medical Society | FG II-I10 | Pharmacist Society | FG III-I10 | Pharmacist Society |
| FG I-I11 | Medical Society | FG III-I11 | Medical Society | ||